Ophthalmology – Chemical Burns
Chemical burns of the eye are serious ocular injuries caused by exposure to corrosive substances such as acids, alkalis, or irritants including solvents and oxidizing agents. These injuries may affect not only the ocular surface but also surrounding facial tissues and, in severe cases, deeper intraocular structures. Alkali burns are generally more severe than acid burns because they penetrate tissues rapidly and cause extensive cellular damage. Chemical eye injuries account for approximately 7–10% of all ocular trauma and are most commonly occupational, particularly among men due to higher industrial exposure.

The severity of injury depends on both the nature of the chemical and the duration of exposure. Alkalis (e.g., ammonia, sodium hydroxide) cause saponification of cell membranes and deep tissue penetration, leading to widespread destruction. In contrast, acids tend to cause protein coagulation, forming a barrier that limits deeper penetration (with the exception of hydrofluoric acid). Damage mechanisms include protein denaturation, collagen disruption, vascular ischemia, and depletion of essential substances such as ascorbate, which impairs healing.
Patients typically present with acute symptoms such as severe pain, photophobia, tearing, blurred vision, and involuntary eyelid closure (blepharospasm). A detailed history, including the type of chemical exposure, is critical. On examination, findings may include corneal epithelial defects, limbal ischemia (seen as pale or blanched areas), stromal haze or opacity, conjunctival damage, and anterior chamber inflammation. In severe cases, there may be elevated intraocular pressure, iris damage, or even lens and ciliary body involvement. The injury evolves through acute, intermediate, and late stages, with potential complications including corneal melting, ulceration, scarring, and symblepharon formation.

Diagnosis is primarily clinical, supported by pH testing of the ocular surface to determine whether the offending agent is acidic or alkaline. Grading systems such as Dua’s classification assess the extent of limbal and conjunctival involvement and help predict prognosis. It is important to recognize that clinical findings can evolve rapidly, and repeated assessment is essential.

Management is an ophthalmic emergency and begins immediately with copious irrigation of the eye using saline or balanced solutions, ideally before full examination. The goal is to normalize the ocular surface pH to around 7. After irrigation, any retained particulate matter must be removed. Medical therapy includes intensive lubrication, topical antibiotics to prevent infection, and cautious use of topical steroids to control inflammation. Additional treatments may include ascorbate (to promote collagen synthesis), citrate (to inhibit tissue breakdown), cycloplegics for pain relief, and intraocular pressure–lowering medications if needed. Pain control and supportive care are also essential.
​
In more severe cases, advanced therapies such as autologous serum drops, amniotic membrane transplantation, or limbal stem cell transplantation may be required. Surgical interventions may also address complications like glaucoma, corneal perforation, or eyelid deformities. Long-term follow-up is crucial to monitor healing and prevent complications.
The prognosis depends largely on the depth and extent of injury. Superficial burns have a good outcome, while severe burns involving the entire limbus and conjunctiva carry a poor prognosis with a high risk of vision loss. Complications can include limbal stem cell deficiency, corneal scarring, glaucoma, cataract formation, and even loss of the eye. Early and aggressive management is critical in improving visual outcomes.

​

Ophthalmology – Chiasmal Disorders
Chiasmal disorders involve pathology affecting the optic chiasm, the structure where nasal retinal fibers from each optic nerve cross. Anatomically, the chiasm lies just above the sella turcica and plays a crucial role in binocular vision by transmitting visual information from both eyes to the brain. Because of this arrangement, lesions in this region classically produce characteristic visual field defects. Visual impairment is often the earliest and most prominent symptom, and notably, nearly one-quarter of all brain tumors occur in the region of the optic chiasm.

The epidemiology of chiasmal disorders is variable and depends on the underlying cause. Pituitary adenomas are among the most common etiologies, with an estimated incidence of about 5 per 100,000 individuals. Visual loss occurs in a significant proportion of these patients, ranging from 30% to 90%. Risk factors include prior radiation exposure and genetic conditions such as neurofibromatosis and multiple endocrine neoplasia. Some inflammatory and demyelinating conditions like multiple sclerosis and sarcoidosis also have genetic predispositions that may involve the chiasm.

Pathophysiologically, most chiasmal syndromes result from compression of the optic chiasm by lesions in the sellar or parasellar region. The crossing nasal fibers are particularly vulnerable, leading to loss of temporal visual fields. Other mechanisms include infiltration, inflammation, ischemia, or trauma. Causes can be intrinsic (such as gliomas) or extrinsic, with extrinsic compressive lesions being the most common. These include pituitary adenomas, craniopharyngiomas, and meningiomas.

Patients often present with visual disturbances such as blurred vision, decreased visual acuity, or visual field defects. The hallmark finding is bitemporal hemianopia, although other patterns like quadrantanopia or junctional scotomas may occur depending on the lesion’s location. Additional symptoms may include diplopia from involvement of adjacent cranial nerves, headache, facial pain, and hormonal disturbances such as amenorrhea, galactorrhea, infertility, or decreased libido due to pituitary involvement. Rare symptoms include oscillopsia and see-saw nystagmus.

On examination, early visual acuity and color vision may remain normal, but visual field testing reveals characteristic defects. A relative afferent pupillary defect may be present if involvement is asymmetric. Over time, optic disc pallor develops in a distinctive “bow-tie” pattern due to selective involvement of nasal and papillomacular fibers. Cranial nerve examination may reveal deficits in nerves III, IV, V, and VI, particularly if the cavernous sinus is involved.

Diagnosis relies heavily on imaging and laboratory evaluation. MRI of the brain and sella with contrast is the investigation of choice, as it provides detailed visualization of soft tissue structures including the optic chiasm. Hormonal evaluation, especially prolactin levels, is important when pituitary lesions are suspected. Optical coherence tomography (OCT) may demonstrate thinning of the retinal nerve fiber layer, supporting the diagnosis. In acute scenarios such as pituitary apoplexy, rapid imaging and intervention are critical.

Management depends on the underlying cause. Corticosteroids are used in inflammatory conditions and acute situations like pituitary apoplexy. Dopamine agonists such as bromocriptine and cabergoline are effective in shrinking prolactin-secreting pituitary adenomas. Surgical intervention, often via transsphenoidal or craniotomy approaches, is required for compressive lesions. Radiation therapy may be considered in selected cases. Multidisciplinary care involving endocrinology, neurosurgery, and ophthalmology is often necessary.
​
The prognosis varies depending on the etiology, duration of compression, and severity of visual loss at presentation. Early diagnosis and treatment improve the likelihood of visual recovery. However, delayed treatment may result in permanent visual deficits. Complications can include persistent visual loss, hormonal imbalances, and life-threatening conditions such as pituitary apoplexy. Regular follow-up with visual field testing and imaging is essential to monitor disease progression and treatment response.

​

Ophthalmology – Child Abuse
Child abuse and neglect, as defined by the Child Abuse Prevention and Treatment Act (CAPTA), refers to any act or failure to act by a caregiver that results in death or serious physical or emotional harm to a child. This includes physical abuse, neglect, and sexual exploitation. In ophthalmology, particular importance is given to abusive head trauma, including shaken baby syndrome (SBS), which is characterized by retinal hemorrhages, intracranial bleeding, and brain injury, often with minimal external signs of trauma. Neglect involves failure to provide essential needs such as food, shelter, supervision, medical care, and education.

Epidemiologically, child abuse remains a major public health concern. Millions of cases are reported annually, with hundreds of thousands confirmed and thousands of deaths each year. Infants and very young children are at the highest risk, particularly those under one year of age. While abuse affects all demographics, certain populations show higher risk rates. Most perpetrators are caregivers, often parents, and contributing factors include social stressors, substance abuse, and underlying family instability.

The pathophysiology of abusive head trauma involves rotational acceleration–deceleration forces that lead to tearing of bridging veins, causing subdural and subarachnoid hemorrhages, as well as diffuse axonal brain injury. Ocular findings result from vitreoretinal traction, producing extensive retinal hemorrhages that are often multilayered and extend to the peripheral retina. In severe cases, traction may also cause retinoschisis and retinal folds. These ocular findings are highly suggestive of abuse, especially when they are numerous and extend beyond the posterior pole.

The diagnosis of child abuse requires a high index of suspicion. Retinal hemorrhages are present in the majority of shaken baby syndrome cases and are often too numerous to count. Clinically, concern should arise when there is a delay in seeking care, inconsistent or changing history, or injuries that are not developmentally plausible. A detailed and carefully documented history is essential, including a clear timeline of events.

On physical examination, a complete systemic evaluation is necessary. Ocular examination with dilated funduscopy is critical and should be performed promptly by an ophthalmologist. Findings may include preretinal, intraretinal, or subretinal hemorrhages, often extending to the ora serrata. Retinoschisis with associated retinal folds is particularly indicative of abusive trauma. Other ocular signs such as hyphema, lens dislocation, or periocular bruising should raise suspicion in the absence of a clear accidental cause. Documentation, including detailed descriptions and photographs when available, is essential for both medical and legal purposes.

Diagnostic evaluation includes imaging and laboratory studies guided by clinical findings. Neuroimaging with CT or MRI often reveals subdural hematomas, cerebral edema, or diffuse axonal injury. A full skeletal survey is recommended in young children to identify occult fractures, especially rib and long bone injuries. Laboratory testing may be used to rule out alternative diagnoses such as coagulopathies or metabolic disorders. While retinal photography can assist in documentation, it does not replace a thorough clinical examination.
​
Management of suspected child abuse is multidisciplinary and urgent. Immediate priorities include stabilization of any life-threatening conditions. Hospitalization is often required for both medical evaluation and protection of the child. Physicians are legally mandated to report suspected abuse to child protective services, even if the diagnosis is not definitively proven. Long-term care involves coordination between medical providers, social services, and mental health professionals to address the needs of the child and family.
Prognosis depends on the severity of injury. Mortality rates in abusive head trauma range from 15% to 38%, and survivors often suffer long-term neurologic and visual complications. These may include cortical visual impairment, optic atrophy, amblyopia, and developmental delays. Severe brain injury correlates strongly with poor visual outcomes. Complications can be profound, including permanent disability, seizures, cerebral palsy, and in the worst cases, death.

​

Ophthalmology – Choroidal Effusion / Detachment
Choroidal effusion or detachment refers to the accumulation of fluid, either serous or hemorrhagic, in the suprachoroidal space. It occurs when fluid or blood collects between the choroid and sclera due to altered pressure relationships or increased vascular permeability. These detachments may occur after trauma, during or after ocular surgery, or more rarely, spontaneously. Serous detachments are often less dramatic in presentation, whereas hemorrhagic choroidal detachments can be painful and visually devastating.

The incidence varies widely, reported between 0.05% and 6%, depending on the clinical setting. There is no clear racial or sex predilection, although hemorrhagic choroidal detachments are more common in elderly patients. Risk factors for serous choroidal effusion include nanophthalmos, uveal effusion syndrome, carotid-cavernous fistula, intraocular inflammation, hypotony, trauma, scleritis, Vogt-Koyanagi-Harada syndrome, tumors, and certain medications. Hemorrhagic detachments are associated with older age, arteriosclerosis, systemic hypertension, uncontrolled glaucoma, myopia, prior ocular surgery, sickle cell disease, and a history of choroidal hemorrhage in the fellow eye. Surgical risk factors include wound leaks, scleral perforation, cyclodialysis clefts, leaking blebs, and prior laser or cryotherapy.
​
The pathophysiology depends on changes in the balance among intraocular pressure, vascular hydrostatic pressure, and oncotic pressure within the suprachoroidal space. Increased vascular permeability allows serum proteins and fluid to exude into this potential space, causing choroidal edema and detachment. In many cases, hypotony is a major precipitating factor. Hemorrhagic detachments occur when blood enters the same space, often after a sudden pressure change or vessel rupture.
Clinically, serous choroidal effusions often cause painless decreased vision and are frequently associated with low intraocular pressure, a shallow anterior chamber, and mild anterior chamber inflammation. On fundus examination, they appear as smooth, bullous, orange elevations of the choroid and retina, often extending circumferentially in the periphery with a lobulated contour. In contrast, hemorrhagic choroidal detachments usually present suddenly with severe pain, marked vision loss, a red eye, and are often associated with elevated intraocular pressure. A careful history should assess for recent surgery, trauma, laser treatment, straining, coughing, Valsalva, and the use of anticoagulants or aspirin.

On examination, it is important to look for evidence of a wound leak, filtering bleb, cyclodialysis cleft, or signs of recent ocular intervention. Seidel testing and gonioscopy may be helpful in identifying the source of hypotony. In selected cases, scalp and skin examination may help identify associated systemic inflammatory disease, such as vitiligo or alopecia in Vogt-Koyanagi-Harada syndrome.

B-scan ultrasonography is the most useful diagnostic tool and typically shows dome-shaped choroidal elevations with low-to-medium internal reflectivity. It helps distinguish serous from hemorrhagic detachments, assesses whether blood is mobile or clotted, and identifies severe appositional detachments known as “kissing choroidals.” Additional imaging such as CT or MRI may help differentiate choroidal effusion from tumors like choroidal melanoma. Transillumination may be positive in serous detachments, whereas hemorrhagic detachments typically do not transilluminate.

Management depends on the underlying cause. Initial treatment includes topical corticosteroids and cycloplegics, along with intraocular pressure control using topical or systemic medications. Oral steroids may be considered when inflammation is a contributing factor. Parasympathomimetic agents are contraindicated as they may worsen the condition.
Surgical intervention may be required if the detachment persists or is severe. Options include posterior sclerotomy to drain suprachoroidal fluid, anterior chamber paracentesis, or injection of viscoelastic substances if the anterior chamber is shallow or flat.

Prognosis depends largely on the underlying etiology. While there is no associated mortality, up to 40% of patients may experience significant vision loss. Hemorrhagic choroidal detachments generally carry a worse prognosis. Potential complications include retinal detachment, cataract formation, glaucoma, corneal endothelial damage, peripheral anterior synechiae, and in severe cases, phthisis bulbi.

​

Ophthalmology – Choroidal Hemangioma
Choroidal hemangioma is a benign vascular tumor of the choroid composed of abnormal blood vessels. It exists in two main forms: circumscribed choroidal hemangioma (CCH), which is a localized solitary lesion without systemic associations, and diffuse choroidal hemangioma (DCH), which is typically associated with Sturge–Weber syndrome. While both forms are benign, they can significantly affect vision due to associated retinal changes.

Epidemiologically, CCH is rare, and DCH is even rarer. CCH typically presents in adulthood, often between the third and sixth decades of life, whereas DCH tends to present earlier, often in childhood or adolescence. There are no known genetic risk factors for CCH, while DCH occurs as part of Sturge–Weber syndrome, a sporadic neurocutaneous disorder characterized by vascular malformations involving the skin, brain, and eye.
The pathophysiology involves proliferation of thin-walled vascular channels within the choroid. These vascular spaces can leak fluid, leading to accumulation of subretinal fluid and serous retinal detachment. Chronic leakage may result in retinal pigment epithelium (RPE) changes, photoreceptor damage, and eventual visual impairment.

Clinically, patients often present with painless visual loss or metamorphopsia. On examination, circumscribed choroidal hemangioma appears as a unilateral, round or oval, orange-red elevated lesion located posterior to the equator. It is frequently associated with serous retinal detachment and overlying retinal changes such as edema or RPE alterations. Diffuse choroidal hemangioma, in contrast, presents as widespread thickening of the choroid, giving a characteristic “tomato ketchup” appearance of the fundus. In these cases, other ocular and systemic features of Sturge–Weber syndrome—such as episcleral vessel dilation and glaucoma—are often present.
​
Diagnostic evaluation includes multimodal imaging. Fluorescein angiography typically shows early hyperfluorescence with progressive leakage. Indocyanine green angiography demonstrates early intense hyperfluorescence followed by a characteristic “washout” pattern in later phases. Ultrasonography reveals a dome-shaped lesion with high internal reflectivity, similar to normal choroidal tissue. Optical coherence tomography is useful in detecting associated retinal changes such as subretinal fluid or macular edema and is particularly helpful for monitoring treatment response.

Management depends on symptoms and the risk to vision. Asymptomatic lesions without vision-threatening complications can be observed. Treatment is indicated when there is subretinal fluid or involvement of the macula. Photodynamic therapy (PDT) with verteporfin is the treatment of choice for circumscribed lesions and is also effective in diffuse cases. Other options include external beam radiotherapy and plaque radiotherapy, particularly in cases not amenable to PDT. Laser photocoagulation and transpupillary thermotherapy are less commonly used due to higher risks of tissue damage.

Prognosis depends largely on the duration and extent of retinal involvement. Early treatment of vision-threatening lesions improves outcomes, while delayed treatment may result in permanent photoreceptor and RPE damage. Complications include persistent serous retinal detachment and, in advanced cases, neovascular glaucoma, which can lead to severe vision loss and may require enucleation. Regular follow-up is essential to monitor for recurrence or progression.

​

Ophthalmology – Choroideremia
Choroideremia is a rare, progressive, X-linked inherited retinal disorder characterized by degeneration of the retinal pigment epithelium (RPE), choroid, and photoreceptors. It primarily affects males, while female carriers are usually asymptomatic or exhibit only mild findings. The disease leads to gradual vision loss over decades, eventually resulting in blindness.

Epidemiologically, choroideremia has an estimated prevalence of approximately 1 in 50,000 individuals. Because it is inherited in an X-linked recessive pattern, it predominantly affects males with a positive family history. Female carriers may occasionally show mild retinal changes but rarely develop significant visual impairment.
​
The underlying genetic defect involves mutations in the CHM gene located on the X chromosome (Xq21.2). This gene encodes the Rab escort protein (REP-1), which is essential for intracellular vesicle transport and normal RPE function. Loss of REP-1 disrupts cellular processes such as phagocytosis of photoreceptor outer segments, lysosomal activity, and intracellular trafficking. These abnormalities ultimately lead to progressive degeneration of the RPE, followed by secondary loss of photoreceptors and choroidal structures.
Clinically, affected males typically present with night blindness (nyctalopia), often beginning in childhood or adolescence. This is followed by progressive peripheral vision loss, initially manifesting as annular scotomas and eventually leading to concentric visual field constriction. By around 40 years of age, many patients have severe peripheral vision loss approaching legal blindness, although central visual acuity is often preserved until later in life.
On examination, early fundus findings include pigmentary changes and patchy areas of RPE and choroidal atrophy in the mid-periphery. As the disease progresses, these areas coalesce, exposing the underlying sclera and leaving only small islands of functioning retina, typically around the macula and optic disc. In advanced stages, the retina appears markedly thinned with extensive choroidal loss.
Diagnosis is primarily clinical but can be confirmed with genetic testing. Functional testing such as visual field analysis and electroretinography (ERG) is useful for assessing disease severity and progression. ERG initially shows a rod-cone degeneration pattern and eventually becomes non-recordable in advanced disease. Imaging modalities such as fluorescein angiography may demonstrate areas of capillary non-perfusion corresponding to atrophic regions.
​
There is currently no definitive treatment for choroideremia. Management focuses on monitoring disease progression and supportive care. Emerging therapies, particularly gene therapy aimed at restoring REP-1 function, show promise but remain under investigation. Patients may benefit from low vision rehabilitation as visual function declines. Protective measures such as UV-blocking sunglasses may help reduce additional retinal stress.

Genetic counseling is an essential component of care, given the X-linked inheritance pattern. Families should be educated about transmission risks, including the 50% chance of carrier mothers passing the mutation to offspring. Prenatal testing may be considered in affected families.

The prognosis involves progressive visual decline. Most affected males develop severe peripheral vision loss by midlife and eventual loss of central vision later in life, leading to blindness. Female carriers generally have a much milder course.

Complications primarily relate to progressive vision loss and its functional consequences, including reduced independence and quality of life. Posterior subcapsular cataracts may also develop in some patients and can be managed surgically if needed.

​

​


Ophthalmology – Choroidal Rupture


Choroidal rupture is a traumatic break involving the choroid, Bruch’s membrane, and the retinal pigment epithelium (RPE), typically resulting from blunt ocular trauma. The injury occurs when the globe is rapidly compressed and then expands, causing mechanical stress that exceeds the tensile strength of Bruch’s membrane. While the sclera and retina are relatively elastic and resistant, Bruch’s membrane is more brittle and prone to tearing.


Epidemiologically, blunt ocular trauma is the most common type of eye injury, and approximately 5–10% of such cases result in choroidal rupture. Most patients have a single rupture, although multiple ruptures can occur in up to 25% of cases. The majority are located temporal to the optic disc, and about two-thirds involve the macula. Although rare in the general population, choroidal rupture is more frequently encountered in individuals with a history of ocular trauma.


The primary risk factor is blunt trauma to the eye, often occurring in younger individuals, particularly males. Patients with pre-existing abnormalities of Bruch’s membrane, such as angioid streaks, are more susceptible and may develop ruptures even after relatively minor trauma. Preventive measures include the use of protective eyewear, especially during contact sports or high-risk activities.


Pathophysiologically, trauma causes rupture of Bruch’s membrane and damage to the underlying choriocapillaris, leading to subretinal or sub-RPE hemorrhage. In the acute phase, hemorrhage and retinal edema may obscure the rupture. As the hemorrhage resolves, the rupture becomes visible as a characteristic white, curvilinear streak, often concentric to the optic disc. Choroidal ruptures are classified as direct (at the site of impact) or indirect (away from the impact site, typically in the posterior pole).


Clinically, patients usually present with a history of blunt trauma followed by decreased vision, central or paracentral scotoma, or visual distortion. On examination, findings may include subretinal hemorrhage and, later, the classic crescent-shaped streak. Additional traumatic findings such as retinal tears, macular holes, or retinal detachment may also be present and should be actively sought.


Diagnosis is primarily clinical but supported by imaging. Fluorescein angiography typically shows an early hypofluorescent streak followed by late hyperfluorescence. Indocyanine green angiography can help identify ruptures obscured by hemorrhage. Optical imaging and B-scan ultrasonography may assist in evaluating associated complications. CT imaging may be required if there is concern for orbital fractures or intraocular foreign bodies.


There is no direct treatment for the rupture itself. Management focuses on identifying and treating associated injuries and complications. Inflammation may be treated with topical steroids and cycloplegics. A key long-term complication is choroidal neovascularization (CNV), which may develop months to years later and is typically treated with anti-VEGF therapy.


Prognosis depends largely on the location of the rupture. Subfoveal ruptures are associated with poor visual outcomes, whereas extrafoveal ruptures often preserve good vision unless complicated by CNV. Many patients do not achieve visual acuity better than 20/40, particularly if the macula is involved.


Complications include CNV (the most common late complication), retinal detachment, and persistent visual field defects. Patients should be monitored closely over time and educated to use tools such as an Amsler grid to detect early visual changes suggestive of CNV development.

Ophthalmology – Choroidal Neovascularization
Choroidal neovascularization (CNV) refers to the formation of abnormal new blood vessels originating from the choroid that penetrate through defects in Bruch’s membrane into the subretinal space. These vessels often form a fibrovascular complex that is fragile and prone to leakage, leading to accumulation of fluid, lipid exudation, and hemorrhage. Over time, this process can result in the formation of a disciform scar and permanent vision loss. CNV is not a standalone disease but a complication of many underlying disorders affecting the retinal pigment epithelium (RPE)–Bruch’s membrane–choriocapillaris complex.
​
Epidemiologically, the incidence and prevalence of CNV vary depending on the underlying condition. It is most commonly associated with age-related macular degeneration (AMD), which is the leading cause of irreversible vision loss in individuals over 65 years in developed countries. Advanced AMD affects tens of millions of people worldwide. The likelihood of developing CNV increases significantly with age and is influenced by systemic and genetic factors.

Risk factors depend largely on the underlying disease. In AMD-related CNV, advancing age, smoking, hypertension, hyperlipidemia, obesity, and reduced physical activity play significant roles. A strong family history also increases risk, reflecting a genetic predisposition. Genetic studies, including twin studies and genome-wide analyses, support the multifactorial inheritance pattern of AMD and its complications such as CNV.

The pathophysiology involves disruption of Bruch’s membrane, which allows neovascular tissue from the choriocapillaris to grow into the subretinal space. This process is driven by proangiogenic factors such as vascular endothelial growth factor (VEGF), platelet-derived growth factor, and other inflammatory mediators. CNV can be classified based on its location relative to the RPE, including type 1 (sub-RPE), type 2 (subretinal), or mixed forms.
Clinically, patients typically present with sudden onset of decreased central vision, often accompanied by metamorphopsia and paracentral scotomas. On examination, findings may include RPE elevation, subretinal fluid, lipid exudates, hemorrhage, and a gray-green lesion beneath the retina. These features reflect the leakage and instability of the neovascular membrane.

Diagnosis is primarily made using imaging techniques. Fluorescein angiography helps identify leakage patterns and differentiate between classic and occult CNV. Optical coherence tomography (OCT) is essential for detecting structural changes such as subretinal fluid, intraretinal edema, and RPE detachment, and is also useful for monitoring response to treatment.

Management has evolved significantly with the advent of anti-VEGF therapy, which is now the standard of care. Intravitreal injections of agents such as ranibizumab or bevacizumab inhibit neovascular growth and reduce leakage, often stabilizing or improving vision. In selected cases, particularly extrafoveal lesions or non-AMD etiologies, laser photocoagulation or photodynamic therapy may be considered. Surgical options such as vitrectomy are reserved for complications like submacular hemorrhage.
​
The prognosis depends on the location of the lesion and the extent of damage at presentation. Early detection and treatment significantly improve visual outcomes. However, recurrence is common, requiring ongoing monitoring with tools such as the Amsler grid and serial imaging.

Complications include subretinal fibrosis, persistent or recurrent fluid accumulation, and, in severe cases, massive subretinal hemorrhage that can lead to retinal detachment and profound vision loss.

​